Literature DB >> 17095343

Assessing adrenal function in primary care settings with a single sample subcutaneous glucagon test.

Michael S Kappy1, Amanda Drake, Dexiang Gao, Rebecca Ratliff.   

Abstract

OBJECTIVE: To test the efficacy of the low-dose glucagon test in assessing adrenal gland function. STUDY
DESIGN: Subcutaneous glucagon was used to assess the hypothalamo-pituitary-adrenal gland (HPA) axis in 215 healthy children. Concordance of this test with the low-dose intravenous ACTH test was established for 42 children. Glucagon testing was conducted for 150 minutes after subcutaneous glucagon administration and for 30 minutes after 1 microg intravenous ACTH.
RESULTS: Mean peak serum cortisol concentrations were 22.4 +/- 0.6 microg/dL (SEM) after subcutaneous glucagon and 20.0 +/- 0.6 microg/dL after intravenous ACTH. Specificity of 95% was found at peak cortisol concentrations of 9.5 and 12.5 microg/dL for the glucagon and ACTH tests, respectively. Concordance between the glucagon and ACTH tests was 90.5%.
CONCLUSIONS: The glucagon test was found to be as good a test of the HPA axis as the ACTH test and had a 90.5% concordance with it. The ease of performing the glucagon test, namely, obtaining a single sample of blood 150 minutes after the subcutaneous administration of glucagon, makes it a useful method of assessing the HPA axis in primary care settings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095343     DOI: 10.1016/j.jpeds.2006.07.033

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

1.  The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults.

Authors:  Zuleyha Karaca; Ayhan Lale; Fatih Tanriverdi; Mustafa Kula; Kursad Unluhizarci; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

2.  Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives.

Authors:  Kevin C J Yuen
Journal:  ISRN Endocrinol       Date:  2011-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.